EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium‐Glucose Cotransporter‐2 Inhibitors

Jaejin An iD, John J Sim, Matt M Zhou, Hui Zhou, Soon Kyu Choi, Jeffrey W Brettler, Angeline L Ong-Su, Kristi Reynolds

The Journal of Clinical Hypertension · 2024

DOI: 10.1111/jch.14915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Hypertension, 2024. Verfasst von Jaejin An und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Hypertension, Antihypertensive Agents, Blood Pressure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) have demonstrated a blood pressure (BP) reduction benefit despite other indications for use. We evaluated BP changes and antihypertensive medication use pre‐ and post‐SGLT2i initiation among 12 960 patients with treated hypertension and among subgroups with apparent treatment‐resistant hypertension (aTRH) and/or proteinuria. Post‐SGLT2i initiation, the mean (SD) systolic blood pressure (SBP) was reduced from 133.9 (16.4) to 128.6 (15.5) mmHg and the mean diastolic blood pressure (DBP) was reduced from 70.8 (11.8) to 68.3 (11.3) mmHg among all patients. The mean SBP/DBP reduction was 5.3/2.5, 6.2/2.8, and 6.1/2.9 mmHg among all patients, patients with aTRH, and patients with proteinuria, respectively. Achieved BP < 130/80 mmHg increased by 12.5%, 16.9%, and 11.1% for all patients, patients with aTRH, and patients with proteinuria, respectively. Discontinuation of ≥ 1 antihypertensive medication within 12 months of SGLT2i initiation occurred in 33.4% overall, 47.6% of patients with aTRH, and 38.7% of patients with proteinuria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsHypertensionAntihypertensive AgentsBlood PressureHumansMaleFemaleMiddle AgedAgedDiabetes Mellitus, Type 2Treatment OutcomeProteinuriaRetrospective Studies

Stichwörter der Autor:innen

SGLT2 inhibitorproteinuriaresistant hypertension

Substanzen

Sodium-Glucose Transporter 2 InhibitorsAntihypertensive Agents

Autor:innen und Institutionen

  • Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
  • Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA.
  • Kaiser Permanente West Los Angeles Medical Center, Los Angeles, California, USA.
  • Kaiser Permanente Panorama City Medical Center, Panorama City, California, USA.

ORCID-Profile: Jaejin An

Zitieren

APA

An, J., Sim, J. J., Zhou, M. M., Zhou, H., Choi, S. K., Brettler, J. W., Ong-Su, A. L., & Reynolds, K. (2024). Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium‐Glucose Cotransporter‐2 Inhibitors. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14915

Vancouver

An J, Sim JJ, Zhou MM, Zhou H, Choi SK, Brettler JW, et al. Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium‐Glucose Cotransporter‐2 Inhibitors. The Journal of Clinical Hypertension. 2024. doi:10.1111/jch.14915

BibTeX
@article{An2024,
  author = {An, Jaejin and Sim, John J and Zhou, Matt M and Zhou, Hui and Choi, Soon Kyu and Brettler, Jeffrey W and Ong-Su, Angeline L and Reynolds, Kristi},
  title = {Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium‐Glucose Cotransporter‐2 Inhibitors},
  journal = {The Journal of Clinical Hypertension},
  year = {2024},
  doi = {10.1111/jch.14915}
}
Kostenlos starten →